Abstract
Although psilocybin has been trained in the rat as a discriminative stimulus, little is known of the pharmacological receptors essential for stimulus control. In the present investigation rats were trained with psilocybin and tests were then conducted employing a series of other hallucinogens and presumed antagonists. An intermediate degree of antagonism of psilocybin was observed following treatment with the 5-HT2A receptor antagonist, M100907. In contrast, no significant antagonism was observed following treatment with the 5-HT1A/7 receptor antagonist, WAY-100635, or the DA D2 antagonist, remoxipride. Psilocybin generalized fully to DOM, LSD, psilocin, and, in the presence of WAY-100635, DMT while partial generalization was seen to 2C-T-7 and mescaline. LSD and MDMA partially generalized to psilocybin and these effects were completely blocked by M-100907; no generalization of PCP to psilocybin was seen. The present data suggest that psilocybin induces a compound stimulus in which activity at the 5-HT2A receptor plays a prominent but incomplete role. In addition, psilocybin differs from closely related hallucinogens such as 5-MeO-DMT in that agonism at 5-HT1A receptors appears to play no role in psilocybin-induced stimulus control.
| Original language | English |
|---|---|
| Pages (from-to) | 472-480 |
| Number of pages | 9 |
| Journal | Pharmacology Biochemistry and Behavior |
| Volume | 87 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2007 |
Keywords
- 2C-T-7
- Bufotenine
- Drug discrimination
- Ketanserin
- LSD
- M100907
- MDMA
- PCP
- Psilocybin
- Rat
- WAY-100635
Fingerprint
Dive into the research topics of 'Psilocybin-induced stimulus control in the rat'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver